Oral contraceptives and venous thromboembolism: Consensus opinion from an international workshop held in Berlin, Germany in December 2009

[No abstract available]

Authors
Reid R.L.1 , Westhoff C.2 , Mansour D.3 , De Vries C. , Verhaeghe J.5 , Boschitsch E.6 , Gompel A.7 , Birkhäuser M.8 , Křepelka P.9 , Duliček P.10 , Iversen O.-E.11 , Khamoshina M. 12 , Dežman L.V.13 , Fruzzetti F.14 , Szarewski A.15 , Wilken-Jensen C.16 , Seidman D.17 , Kaaja R.18 , Shapiro S.19
Publisher
Royal College of Obstetricians and Gynaecologists
Number of issue
3
Language
English
Pages
117-122
Status
Published
Volume
36
Year
2010
Organizations
  • 1 Department of Obstetrics and Gynecology, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
  • 2 Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY, United States
  • 3 NHS Newcastle and North Tyneside, Community Health, New Croft Centre, Newcastle upon Tyne, United Kingdom
  • 4 Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom
  • 5 Department of Obstetrics and Gynecology, Katholieke Universiteit Leuven, Leuven, Belgium
  • 6 Ambulatorium KLIMAX, Wien, Austria
  • 7 Service de Gynécologie, Université Paris Descartes, Paris, France
  • 8 Department of Obstetrics and Gynaecology, University of Berne, Base, Switzerland
  • 9 Institute for Care of Mother and Child, Podolske Nabrezi, Prague, Czech Republic
  • 10 Division of Clinical Haematology, University Hospital, Hradec Králové, Sokolská, Czech Republic
  • 11 Institutt for Klinisk Medisin, Seksjon for Gynekologi og Obstetrikk, Haukeland Universitetssykehus, Bergen, Norway
  • 12 Department of Obstetrics and Gynecology, RUDN, People Friendship University of Russia, Moscow, Russian Federation
  • 13 Gynaecological Clinic, Health Centre Kranj, Gosposvetska, Kranj, Slovenia
  • 14 Department of Obstetrics and Gynecology, Ospedale S Chiara, Pisa, Italy
  • 15 Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, London, United Kingdom
  • 16 Region Sjælland, Gynækologisk-obstetrisk Afdeling, Roskilde Sygehus, Køgevej, Roskilde, Denmark
  • 17 Department of Obstetrics and Gynecology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • 18 Turku University, Satakunta Central Hospital, Pori, Finland
  • 19 Department of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Keywords
activated protein C; ceruloplasmin; desogestrel; drospirenone; drospirenone plus ethinylestradiol; estrogen; gestagen; gestodene; ingenix; levonorgestrel; liver protein; oral contraceptive agent; phospholipid antibody; sex hormone binding globulin; transcortin; unclassified drug; oral contraceptive agent; progesterone; abortion; acne; awareness; body mass; breakthrough bleeding; cardiovascular risk; cigarette smoking; clinical trial; conference paper; deep vein thrombosis; delivery; demography; disease marker; disease registry; Doppler flowmetry; drug dose reduction; drug formulation; drug marketing; drug safety; drug surveillance program; dysmenorrhea; endometrium cancer; family history; follow up; food and drug administration; hazard ratio; heredity; hirsutism; hormonal contraception; hormonal therapy; human; immobilization; law suit; leg pain; leg swelling; lung embolism; medical decision making; medical documentation; menopause; menstrual migraine; menstruation; obesity; oral contraception; ovary cancer; patient assessment; postmarketing surveillance; premenstrual syndrome; prescription; public health; risk benefit analysis; thrombophilia; treatment duration; treatment response; United States; unplanned pregnancy; unwanted pregnancy; venous thromboembolism; weight gain; chemically induced; consensus; consensus development; female; Germany; health; international cooperation; public relations; risk factor; venous thromboembolism; women's health; Consensus; Contraceptives, Oral, Hormonal; Female; Germany; Global Health; Humans; Internationality; Interprofessional Relations; Progesterone; Risk Factors; Venous Thromboembolism; Women's Health
Date of creation
19.10.2018
Date of change
19.10.2018
Short link
https://repository.rudn.ru/en/records/article/record/2847/